• Tilray Brands (TLRY) has announced that its medical cannabis division, Tilray Medical, has released new medical cannabis products under Tilray and Aphria brands
  • Tilray Medical also launched CannaPoints, a new program to support patients through their medical cannabis journey
  • Tilray Medical’s latest release of medical cannabis products from differentiated brands includes a comprehensive range of THC and CBD products
  • Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis
  • Tilray Stock (TSX:TLRY) opened the day’s trading at $4.88 per share

Tilray Brands (TLRY) has announced that its medical cannabis division, Tilray Medical, has released new medical cannabis products, under Tilray and Aphria brands.

Tilray Medical also launched CannaPoints, a new program to support patients through their medical cannabis journey.

“We’re proud to expand our medical cannabis portfolio in Canada and broaden our offerings for our growing patient community,” said Blair MacNeil, President, Tilray Canada.

“Our new CannaPoints program serves to guide our patients on their medical cannabis journey and provide additional support as needed,” he added.

In Canada, Tilray Medical offers a broad portfolio of medical cannabis brands including Tilray, Aphria, Broken Coast, and Symbios.

Tilray Medical’s latest release of medical cannabis products from differentiated brands includes a comprehensive range of THC and CBD products.

Under the Tilray and Aphria brands, the company released Tilray Sinaloa Gold, Tilray Sapphire Scout, Tilray Chem Cookies, and Tilray Powdered Donuts #8. And under the Aphria brands, it released Aphria Sherbet Cookies, Aphria Banana Punch, and Aphria Monkey Butter.

To further support the medical cannabis journey for patients, Tilray Medical partnered with Strainprint, a mobile app focused on medical cannabis tracking, to develop the CannaPoints
program.

Alongside advice from a physician, Tilray Medical patients can use the CannaPoints program to explore new offerings, learn more about strain details, and record the effects, making it easier for them to curate optimal personal consumption schedules, empowering them to tailor their own experiences and earn rewards through the app in the process.

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis.


More From The Market Online

Greenway Cannabis notches global cannabis accreditation

Greenway Greenhouse Cannabis (CSE:GWA) receives CUMCS-G.A.P and GACP certification for its cultivation facility in Ontario.

The Market Online’s Weekly Cannabis Report – April 26, 2024

Tilray has been garnering attention lately. Its subsidiary, Montauk Brewing Company, announced the return of Project 4:20 India Pale Ale

Buzz on the Bullboards: A recap of recent activity and stocks in focus

After a major sell-off, stock markets have been on edge, monitoring corporate earnings to gauge the direction of the economy.

Unsung profits: Three microcap stocks with a strong case for value

A key factor behind picking winning microcap value stocks is identifying dislocations between company performance and market perception.